Skip to main content
. Author manuscript; available in PMC: 2016 Mar 22.
Published in final edited form as: Clin Cancer Res. 2007 Dec 1;13(23):7133–7138. doi: 10.1158/1078-0432.CCR-07-0874

Table 2.

Dose-escalation of irinotecan

Dose (mg/m2) No. of patients
350 6
400 3
450 3
500 6
550 2*
500 12
*

These two patients developed grade 3 toxicity; thereafter, 12 additional patients were enrolled into the expansion portion of the study to further assess irinotecan toxicity.

Expansion cohort.